stock offering
Natera Prices, Upsizes Public Stock Offering
The company said it plans to use the proceeds for working capital and general corporate purposes, and continued investments in R&D for its core technology.
Sera Prognostics Goes Public With $75M IPO
The firm is offering 4,687,500 shares of its common stock at $16 per share. Its first commercial product is the PreTRM test for predicting the risk of a preterm birth.
Angle to Raise £20M Through Stock Placement
The company said the proceeds of the offering will be used in part to continue development of its flagship Parsortix tumor cell-sorting system in prostate cancer.
Oncocyte Inks At-Market Agreement to Sell Up to $50M in Stock
The company said any proceeds raised will help continue commercialization of its lead test, DetermaRx, and fund the development of the rest of its pipeline.
SomaLogic to Go Public Through Merger With Special Purpose Acquisition Company
Following the transaction, which values the company at roughly $1.2 billion and will provide cash proceeds of around $650 million, SomaLogic will list on the Nasdaq.